High in-vitro antitumour activity of triphenyltin coumarin-3-carboxylate and its coordination complexes with monodentate oxygen donor ligands against the Epstein Barr virus (EBV)- DNA positive Raji and the P-388 murine leukaemia cell lines, and evidence for the suppression by organotin of the early antigen complex in the EBV lytic cycle

Metal-Based Drugs

Volumn 7, Issue 5, 2000, Pages 245-251

  Koshy, Joyce ^a   Kumar Das, V G ^a   Balabaskaran, S ^a   Ng, S W ^a   Wahab, Norhanom ^b  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTINEOPLASTIC METAL COMPLEX; ARSINE DERIVATIVE; BUTYRIC ACID; DIPHENCYPRONE; DNA; EARLY ANTIGEN; FLUOROURACIL; ORGANOTIN COMPOUND; PHORBOL 12 ACETATE 13 MYRISTATE; PROTEIN; QUINOLINE DERIVATIVE; TRANSACTIVATOR PROTEIN; TRIPHENYLPHOSPHINE; TRIPHENYLTIN COUMARIN 3 CARBOXYLATE; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL CYCLE; COMPARATIVE STUDY; COMPLEX FORMATION; CONTROLLED STUDY; DNA CLEAVAGE; DRUG SYNTHESIS; EPSTEIN BARR VIRUS; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LETHAL DOSE; LEUKEMIA P 388 CELL; LYMPHOMA CELL LINE; LYSIS; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PROTEIN RESTRICTION; RAJI CELL;

EID: 0034443545     PISSN: 07930291     EISSN: None     Source Type: Journal    
DOI: 10.1155/MBD.2000.245     Document Type: Article

References (23)

1. M.Gielen, P.Lelieveld, D.de Vos and R.Willem. In "Metal Complexes in Cancer Chemotherapy" (Ed: B.K.Keppler), VCH, Weinheim, 1993, Chapter 17, p.383;
2. M.Gielen, Coord.Chem.Rev., 151 (1966)41.
3. M.Gielen, A.El Khloufi, M.Biesemans, A.Bouhdid, D.de Vos, B.Mahieu and R.Willem, Metal-based Drugs, 1 (1994) 305;
4. M.Gielen, A.El Khloufi, M.Biesemans, F.Kayser and R.Willem, Appl.Organomet.Chem., 7 (1993) 201, and references therein.
5. Y.Arakawa. In "Chemistry and Technology of Silicon and Tin" (Eds: V.G.Kumar Das, S.W.Ng and M.Gielen), Oxford Sc.Publ., Oxford, 1992, Chapter 23 p.319.
6. nd edn., Blackie Academic & Professional, London, 1998, Chapter 10, p.388.
7. A.J.Crowe, Metal-based Drugs, 1 (1989) 103.
8. S.W.Ng, V.G.Kumar Das and M.Gielen, Appl.Organomet.Chem.,6 (1992) 489;
9. S.W.Ng, V.G.Kumar Das, M.Gielen and E.R.T.Tiekink, Appl.Organomet.Chem., ibid, 6 (1992) 19;
10. S.W.Ng, V.G.Kumar Das, J.Holecek, A.Lyeka, M.Gielen and M.G.B.Drew, Appl.Organomet.Chem.,ibid, 11 (1997) 39.
11. M.J.Porter, J.K.Field, J.C.K.Lee, S.F.Leung, D.Lo and C.A.van Hasselt, Anticancer Res., 14 (1994) 1357.
12. G.Niedobitek, M.L.Hansmann, H.Herbst, L.S.Young, D.Dieneman, T.Finn, C.A.Hartmann, S.Pitteroff, A.Welt, LAnagnostopoulos, R.Friedrich, H.Lobeck, L.K.Sam, I.Aranjo, A.B.Rickinson and H.Stein, J.Pathology, 165 (1991) 17.
13. S.D.Kottaridis, E.Panatopoulou, I.Diamantis, I.Goula, J.Danilidis and G.Fountzilas, Anticancer Res., 16 (1996) 785.
14. J.Luka, J. Virological Methods, 21 (1988) 223, and references therein.
15. Q.Liu and W.C.Summers, J. Virology, 63 (1989) 5062.
16. J.Countryman, H.Jenson, R.Seibl, H. Wolf and G.Miller, J. Virology, 61 (1987) 3672.
17. M.Kawanishi and Y.Ito, Cancer Lett., 16 (1982) 19.
18. G.Henle, W.Henle and G.Klein, Int.J.Cancer, 8 (1971) 272.
19. S.W.Ng and V.G.Kumar Das, Trends in Organomet.Chem., 2 (1997) 107;
20. Acta Cryst, C53 (1997) 1034
21. nd edn., 1993, Chapter 13, Longman Scientific & Technical, Harlow (UK)
22. I.Saito, Bo Servenius, T.Compton and R.I.Fox, J.Exp.Med.,169 (1989) 2191
23. G.R.Pearson, B.Vroman, B.Chase, T.Sculley, M.Hummel and E.Kieff, J. Virology,47 (1983) 193